Kazumasa Komura

Title: Kazumasa Komura: Innovator in Prostate Cancer Diagnosis

Introduction

Kazumasa Komura is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of prostate cancer. With a total of 2 patents, his work is paving the way for advancements in medical diagnostics.

Latest Patents

Kazumasa Komura's latest patents focus on compositions and methods for screening and diagnosing prostate cancer. The inventions provide methods for identifying patients with hormone-sensitive prostate cancer who would benefit from primary castration and taxane treatments. Additionally, they help determine which patients with castration-resistant prostate cancer would benefit from docetaxel combined with androgen receptor antagonists. The patents also highlight the importance of KDM5D expression levels in predicting the clinical course of prostate cancer, indicating that lower expression levels may correlate with a more aggressive form of the disease.

Career Highlights

Kazumasa Komura is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to work on innovative solutions for cancer diagnosis and treatment. His research is instrumental in improving patient outcomes and advancing the understanding of prostate cancer.

Collaborations

He collaborates with esteemed colleagues such as Philip W. Kantoff and Christopher Sweeney, contributing to a collective effort in cancer research and treatment.

Conclusion

Kazumasa Komura's work in prostate cancer diagnosis exemplifies the impact of innovation in the medical field. His patents and collaborations are vital in enhancing the understanding and treatment of this prevalent disease.